We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Genetic Mutations Identified in Human Blood Diseases

By LabMedica International staff writers
Posted on 13 May 2014
Print article
Image: The UniCel DxH 800 cellular analysis system (Photo courtesy of Beckman Coulter).
Image: The UniCel DxH 800 cellular analysis system (Photo courtesy of Beckman Coulter).
A dozen mutations have been identified in the human genome that are involved in significant changes in complete blood counts and that explain the onset of occasionally severe biological disorders.

The number of red and white blood cells and platelets in the blood is an important clinical marker, as it helps doctors detect many hematological and other diseases and can also be used to determine the effectiveness of therapy for certain pathologies.

Scientists at the Montreal Heart Institute (MHI; Montreal, QC, Canada) and their international collaborators analyzed the DNA of 6,796 people who had donated specimens to the MHI Biobank by looking specifically at segments of DNA directly involved in protein function in the body. They also analyzed hemoglobin concentration, hematocrit levels, white blood cell (WBC) counts and platelet counts in 31,340 individuals genotyped on an exome array.

Blood cell counts and other related phenotypes were automatically generated with the UniCel DxH 800 cellular analysis system (Beckman Coulter; Brea, CA, USA). DNA samples from the clinical coordinating center were sent for genotyping and were placed on 96-well plates for processing using the HumanExome v1.0 Single Nucleotide Polymorphism (SNP) array (Illumina; San Diego, CA, USA).

The scientists specifically identified a significant mutation in the gene that encodes erythropoietin (EPO), a hormone that controls the production of red blood cells. They also identified a mutation in the Janus kinase 2 (JAK2) gene, which is responsible for a 50% increase in platelet counts and, in certain cases, for the onset of bone marrow diseases that can lead to leukemia.

The authors concluded that their results clearly demonstrated that rare and low-frequency coding variants contribute to phenotypic variation in human populations. The new missense variants in key regulators of hematopoiesis that were discovered have potential implications for diagnostic screening and drug development in a variety of hematological and inflammatory disorders. The study was published on April 28, 2014, in the journal Nature Genetics.

Related Links:

Montreal Heart Institute
Beckman Coulter 
Illumina 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.